持续葡萄糖监测作为早期1型糖尿病工具
本文综述了持续葡萄糖监测(CGM)在早期1型糖尿病中的应用依据、证据和实际考量。CGM可检测早期高血糖及其他血糖异常,弥补空腹血糖、HbA1c和OGTT等现有筛查分期方法的不足,但作为筛查、分期和监测工具及临床终点仍面临技术、分析和监管挑战。
要点
- CGM在早期1型糖尿病中可检测早期高血糖及其他血糖异常。
- 现有筛查方法如空腹血糖、HbA1c和OGTT受限于偶测采样、受试者负担和可重复性变异。
- CGM作为早期1型糖尿病筛查、分期和监测工具及临床终点仍需解决技术、分析和监管挑战。
核心结论
- CGM有潜力补充现有代谢和免疫标志物,用于早期1型糖尿病的筛查、分期和监测,但需解决技术、分析和监管挑战才能成为可靠工具和临床终点。
研究设计与样本
- 本文为综述,检索范围未在摘要中报告。
主要发现
- 在已确诊1型糖尿病中,CGM衍生的血糖管理指标如目标范围内时间、高于范围时间、低于范围时间和血糖变异性已成为优化治疗、减少低血糖和指导临床决策的整合工具。
- 在早期1型糖尿病中,CGM emerged as a promising tool to detect early hyperglycaemia and other glucose abnormalities。
- 现有筛查和分期方法包括空腹血糖、HbA1c和OGTT,仍受限于偶测采样、受试者负担和可重复性变异。
临床怎么用
- 临床可考虑将CGM整合到早期1型糖尿病研究和临床框架中,以补充现有代谢和免疫标志物。
局限性
- CGM作为早期1型糖尿病筛查、分期和监测工具及临床终点,仍需解决技术、分析和监管挑战。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Continuous glucose monitoring (CGM) has transformed diabetes management by providing continuous, real-time insights into glucose dynamics, while enhancing the lived experience of individuals with type 1 diabetes. In established type 1 diabetes, CGM-derived measures of glucose management, such as time in range, time above range, time below range and glycaemic variability, have become integral tools to optimise therapy, reduce episodes of hypoglycaemia and guide clinical decision-making. More recently, CGM has emerged as a promising tool to detect early hyperglycaemia and other glucose abnormalities in individuals with early-stage type 1 diabetes, for whom current screening and staging methods, including fasting glucose, HbA1c and the OGTT, remain limited by episodic sampling, participant burden and variable reproducibility. This review examines the rationale, evidence and practical considerations for integrating CGM into early-stage type 1 diabetes research and clinical frameworks. We discuss its potential to complement existing metabolic and immunological markers, as well as the technical, analytical and regulatory challenges that must be addressed for CGM to serve as a reliable tool for screening, staging and monitoring and as a clinical endpoint in early-stage type 1 diabetes.
引用
- Carr ALJ, Sutton H, Agesen RM, et al. Continuous glucose monitoring as a tool in early-stage type 1 diabetes. Diabetologia. 2026. PMID: 41803288. doi:10.1007/s00125-026-06707-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。